Moreover, in order to explore the effect of PACSIN1 on the survival of glioma patients, this study analyzed the PACSIN1 expression in the survival time and status of 325 samples in the CGGA dataset and 603 samples in the TCGA dataset, and found that patients with lower expression of PACSIN1 had significantly shorter OS in all grades of gliomas (Figure 5). Here, PACSIN1 is linked to central nervous system cancer.